- •Foreword
- •Preface
- •Contents
- •Contributors
- •Introduction
- •Noninfectious Retinal Manifestations
- •Cytomegalovirus Retinitis
- •Necrotizing Herpetic Retinitis (by Varicella Zoster)
- •Toxoplasmic Retinochoroiditis
- •Syphilitic Uveitis, Papillitis, and Retinitis
- •Candida Vitritis and Retinitis
- •Pneumocystis carinii Choroiditis
- •Cryptococcus neoformans Chorioretinitis
- •Mycobacterium Choroiditis
- •B-Cell Lymphoma
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Etiologic Agent
- •Toxocara canis
- •Ancylostoma caninum
- •Baylisascaris procyonis
- •Trematodes
- •Mode of Transmission
- •Diagnosis and Pathogenesis
- •Early Stage
- •Late Stage
- •Ancillary Tests
- •Serologic Test
- •Fluorescein Angiography
- •Visual Field Studies
- •Scanning Laser Ophthalmoscopy (SLO)
- •Optic Coherence Tomography (OCT)
- •GDx® Nerve Fiber Analyzer
- •Differential Diagnosis
- •Management
- •Laser Treatment
- •Oral Treatment
- •Pars Plana Vitrectomy (PPV)
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Epidemiology
- •Etiology and Pathogenesis
- •Systemic Manifestations
- •Clinical Intraocular Manifestations
- •Diagnosis
- •Treatment
- •Surgical Technique
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Pathogenesis and Life Cycle
- •Clinical Manifestations
- •Epidemiology
- •Diagnosis
- •Differential Diagnosis
- •Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Current Epidemiology
- •Eyelid Tuberculosis
- •Conjunctival Tuberculosis
- •Scleral Tuberculosis
- •Phlyctenulosis
- •Corneal Tuberculosis
- •Uveal Tuberculosis
- •Anterior Uveitis
- •Intermediate Uveitis
- •Posterior Uveitis (Choroidal Tuberculosis)
- •Orbital Tuberculosis
- •Retinal Tuberculosis
- •Retinal Vascular Disease
- •Tuberculous Panophthalmitis
- •Neuro-ophthalmological Aspects
- •Ocular Tuberculosis Associated with Mycobacterium bovis
- •Rare Presentations
- •Isolated Macular Edema
- •Isolated Ocular Tuberculosis
- •Intraocular Infection with Pigmented Hypopyon
- •Ocular Tuberculosis After Corticosteroid Therapy
- •Systemic Investigations
- •Ocular Investigations
- •Corticosteroid Therapy
- •Antitubercular Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Pathogenesis
- •Clinical Manifestations
- •Epidemiology
- •Diagnosis
- •Differential Diagnosis
- •Management
- •Pyrimethamine
- •Sulfonamides
- •Folinic Acid
- •Clindamycin
- •Azithromycin
- •Trimethoprim and Sulfamethoxazole
- •Spiramycin
- •Atovaquone
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Bartonellosis
- •Epidemiology
- •Microbiology
- •Clinical Findings in Cat Scratch Disease
- •Systemic Manifestations
- •Ocular Manifestations
- •Parinaud’s Oculoglandular Syndrome (POGS)
- •Retinal and Choroidal Manifestations and Complications
- •Neuroretinitis (Leber’s Neuroretinitis)
- •Multifocal Retinitis and Choroiditis
- •Vasculitis and Vascular Occlusion
- •Peripapillary Bacillary Angiomatosis
- •Uveitis
- •Diagnosis
- •Biopsy and Testing
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •Lyme Disease
- •Diagnosis
- •Ocular Manifestations
- •Intermediate Uveitis
- •Retinal Vasculitis, Branch Retinal Artery, Retinal Vein Occlusion, and Cotton-Wool Spots
- •Neuroretinitis
- •Other Ocular Manifestations
- •Cystoid Macular Edema and Macular Pucker
- •Retinal Pigment Epithelial Detachment
- •Retinitis Pigmentosa-Like Retinopathy
- •Choroidal Neovascular Membrane
- •Acute Posterior Multifocal Placoid Pigment Epitheliopathy-Like Picture
- •Retinal Tear
- •Ciliochoroidal Detachment
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •Syphilis
- •Ocular Manifestations
- •Retina and Choroid
- •Retinal Vasculature
- •Optic Disk
- •Association Between HIV and Syphilis
- •Clinical Importance of Ocular Syphilis
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •References
- •Introduction
- •Acute Retinal Necrosis
- •Causative Virus
- •Epidemiology
- •Virological Diagnosis
- •Clinical Course
- •Treatment
- •Cytomegalovirus
- •Diagnosis
- •Staging and Progression
- •Laboratory Findings
- •Treatment
- •Pharmacologic
- •Surgical
- •Patient Follow-up
- •Epidemiology
- •Diagnosis
- •HIV Disease
- •HIV Therapy
- •Ocular Manifestations of HIV
- •Progressive Outer Retinal Necrosis
- •Diagnosis
- •Etiology
- •Therapy
- •Rubella
- •West Nile Virus
- •Other Systemic Illnesses
- •Controversies and Perspectives
- •What Is the Best Surgical Approach for Repair of Secondary Retinal Detachment?
- •Focal Points
- •References
- •Introduction
- •Causative Organisms
- •Candidiasis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Aspergillus Retinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Cryptococcal Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Coccidioides immitis Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Histoplasma Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Sporothrix schenckii Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Controversies and Perspectives
- •Focal Points
- •References
- •10: Endogenous Endophthalmitis
- •Introduction
- •Clinical Findings
- •Diagnosis
- •How to Culture
- •Polymerase Chain Reaction
- •Treatment
- •Systemic Antibiotics
- •Intravitreous Antibiotics
- •Corticosteroid Therapy
- •Vitrectomy
- •Prognosis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Etiology
- •Genetic Features
- •Immunopathogenesis
- •Diagnosis
- •Posterior Segment Findings
- •Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Epidemiology
- •Prevalence and Incidence
- •Age of Onset
- •The Gender Factor
- •Etiopathogenesis
- •Clinical Features and Diagnosis
- •Ocular Involvement
- •Posterior Segment Involvement
- •Fluorescein Angiography
- •Indocyanine Green Angiography
- •Optical Coherence Tomography
- •Other Ocular Manifestations
- •Complications
- •Histopathology
- •Prognosis of Ocular Disease
- •Juvenile Behçet’s Disease
- •Pregnancy and Behçet’s Disease
- •Differential Diagnosis
- •Management of Ocular Disease
- •Medical Treatment
- •Colchicine
- •Corticosteroids
- •Intravitreal Triamcinolone
- •Cyclosporin A and Tacrolimus (FK506)
- •Anti-tumor Necrosis Factor Treatment
- •Cytotoxic and Other Immunosuppressive Agents
- •Tolerization Therapy
- •Laser Treatment
- •Plasmapheresis
- •Cataract Surgery
- •Trabeculectomy
- •Vitrectomy
- •Controversies and Perspectives
- •Pearls
- •References
- •13: Intraocular Lymphoma
- •Introduction
- •Historical Background
- •Epidemiology
- •Etiology
- •Imaging
- •Diagnosis and Pathology
- •Treatment
- •Controversies and Perspectives
- •Focal Points
- •Acknowledgments
- •References
- •14: Choroidal and Retinal Metastasis
- •Introduction
- •Primary Cancer Sites Leading to Intraocular Metastasis
- •Intraocular Metastasis Onset
- •Choroidal Metastases
- •Ciliary Body Metastases
- •Iris Metastases
- •Retinal Metastases
- •Optic Disk Metastases
- •Vitreous Metastases
- •Ocular Paraneoplastic Syndromes
- •Diagnostic Evaluation for Ocular Metastasis
- •Systemic Evaluation
- •Fluorescein Angiography
- •Indocyanine Green Angiography
- •Ultrasonography
- •Optical Coherence Tomography
- •Computed Tomography
- •Magnetic Resonance Imaging
- •Fine-Needle Aspiration Biopsy
- •Surgical Biopsy
- •Pathology of Ocular Metastasis
- •Observation
- •Radiotherapy
- •Surgical Excision, Enucleation
- •Patient Prognosis
- •Controversies and Perspective
- •Pearls
- •References
- •Introduction
- •CAR Cases
- •CAR Case 1: CAR Secondary to Esthesioneuroblastoma (Olfactory Neuroblastoma)
- •CAR Case 2: CAR Associated with Metastatic Breast Cancer
- •CAR Case 3: Paraneoplastic Optic Neuritis and Retinitis Associated with Small Cell Lung Cancer
- •Paraneoplastic Retinopathy: Melanoma-Associated Retinopathy (MAR)
- •MAR Case
- •Pearls
- •References
- •Introduction
- •Epidemiology
- •Pathophysiology
- •Clinical Presentation
- •Ulcerative Colitis
- •Crohn’s Disease
- •Ocular Manifestations
- •Posterior Segment Lesions
- •Treatment of Ocular Manifestations
- •Whipple’s Disease
- •Diagnosis
- •Extraintestinal Manifestations
- •Central Nervous System
- •Others
- •Treatment
- •Avitaminosis A
- •Pancreatitis
- •Familial Adenomatous Polyposis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Demographics
- •Genetics
- •Fundus Manifestations
- •Management
- •Demographics
- •Genetics
- •Ophthalmologic Features
- •Fundus Manifestations
- •Management
- •Demographics
- •Genetics
- •Fundus Manifestations
- •Management
- •Genetics
- •Ophthalmologic Features
- •Fundus Manifestations
- •Management
- •Genetics
- •Fundus Manifestations
- •Management
- •Genetics
- •Fundus Manifestations
- •Controversies and Perspectives
- •References
- •Pathogenesis and Laboratory Findings
- •Innate Immune System Activation
- •Increased Availability of Self-antigen and Apoptosis
- •Adaptive Immune Response
- •Damage to Target Organs
- •General Clinical Findings
- •Ocular Symptoms
- •Posterior Ocular Manifestations
- •Mild Retinopathy
- •Vaso-occlusive Retinopathy
- •Lupus Choroidopathy
- •Anterior Visual Pathway
- •Posterior Visual Pathway
- •Oculomotor System
- •Anterior Ocular Manifestations
- •Drug-Related Ocular Manifestations
- •General Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •19: Vogt–Koyanagi–Harada Disease
- •Introduction
- •History
- •Epidemiology
- •Immunopathogenesis
- •Histopathology
- •Immunogenetics
- •Clinical Features
- •Extraocular Manifestations
- •Ancillary Test
- •Fluorescein Angiography (FA)
- •Indocyanine Green Angiography (ICGA)
- •Cerebrospinal Fluid Analysis (CSF)
- •Ultrasonography (USG)
- •Ultrasound Biomicroscopy (UBM)
- •Magnetic Resonance Image (MRI)
- •Electrophysiology
- •Differential Diagnosis
- •Sympathetic Ophthalmia
- •Primary Intraocular B-Cell Lymphoma
- •Posterior Scleritis
- •Uveal Effusion Syndrome
- •Sarcoidosis
- •Lyme Disease
- •Treatment
- •Complications
- •Prognosis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •General
- •Genetics
- •Pathogenesis
- •Ocular Pathology
- •Lens
- •Retina
- •Lens Subluxation
- •Clinical Findings
- •Pathogenesis
- •Differential Diagnosis
- •Treatment
- •Retinal Detachment
- •Clinical Findings
- •Pathogenesis
- •Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •21: Diabetic Retinopathy
- •Introduction
- •Pathogenesis
- •Risk Factors
- •Duration of Disease
- •Glucose Control
- •Blood Pressure Control
- •Lipid Control
- •Other Factors
- •Proliferative Diabetic Retinopathy
- •Advanced Eye Disease
- •Diabetic Macular Edema
- •Management
- •Glycemic Control
- •Blood Pressure Control
- •Serum Lipid Control
- •Aspirin Treatment
- •Laser Photocoagulation
- •Vitrectomy
- •Pharmacotherapy
- •Corticosteroids
- •Triamcinolone Acetonide
- •Fluocinolone Acetonide
- •Extended-Release Dexamethasone
- •Pegaptanib
- •Ranibizumab
- •Bevacizumab
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Hypertensive Retinopathy
- •Hypertensive Choroidopathy
- •Indirect Effects
- •Controversies and Perspectives
- •Summary
- •Focal Points
- •References
- •Introduction
- •Anemia
- •Aplastic Anemia
- •Hemoglobinopathies
- •Sickle Cell Disease
- •Thalassemia
- •Deferoxamine Toxicity
- •Autoimmune Hemolytic Anemia
- •Antiphospholipid Antibody Syndrome
- •Hemophilia and Platelet Disorders
- •Myelodysplastic Disorders
- •Myeloproliferative Disorders
- •Chronic Myelogenous Leukemia
- •Polycythemia Vera
- •Essential Thrombocythemia
- •Leukemias
- •Acute Myeloid Leukemia
- •Lymphoid
- •Lymphomas
- •B Cell Lymphoma
- •Hodgkin’s Lymphoma
- •Plasma Cell Disorders
- •Plasmacytoma/Multiple Myeloma
- •Plasma Cell Leukemia
- •T Cell Lymphomas
- •Controversies/Perspectives
- •Roth Spots
- •Anti-VEGF Therapy
- •Focal Points
- •Anemia
- •Hemoglobinopathies
- •Myelodysplastic Syndrome
- •Myeloproliferative Neoplasms
- •Leukemia
- •Lymphoma
- •References
- •24: The Ocular Ischemic Syndrome
- •Introduction
- •Demography
- •Etiology
- •Symptoms
- •Loss of Vision
- •Amaurosis Fugax
- •Pain
- •Visual Acuity
- •Signs
- •External
- •Anterior Segment Changes
- •Posterior Segment Findings
- •Diagnostic Studies
- •Fluorescein Angiography
- •Electroretinography
- •Carotid Artery Imaging
- •Others
- •Systemic Associations
- •Differential Diagnosis
- •Treatment
- •Systemic Therapy: Carotid Artery
- •Ophthalmic Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •25: Ocular Manifestations of Pregnancy
- •Introduction
- •Physiologic Changes
- •Intraocular Pressure
- •Cornea
- •Pathologic Conditions
- •Pregnancy-Induced Hypertension
- •Clinical Features
- •Ocular Manifestations
- •HELLP Syndrome
- •Management of PIH
- •Prognosis
- •Central Serous Retinopathy
- •Occlusive Vascular Disorders
- •Purtscher’s-Like Retinopathy
- •Disseminated Intravascular Coagulation (DIC)
- •Thrombotic Thrombocytopenic Purpura (TTP)
- •Amniotic Fluid Embolism
- •Preexisting Conditions
- •Diabetic Retinopathy
- •Progression
- •Factors Associated with Progression
- •Pathophysiology of Progression
- •Treatment Criteria for Diabetic Retinopathy
- •Follow-up Guidelines
- •Intraocular Tumors
- •Uveal Melanoma
- •Choroidal Osteoma
- •Choroidal Hemangioma
- •Ocular Medications
- •Topical Drops
- •Diagnostic Agents
- •Summary
- •Focal Points
- •References
- •Introduction
- •Toxicity with Diffuse Retinal Changes
- •Toxicity with Pigmentary Degeneration
- •Quinolines
- •Phenothiazines
- •Deferoxamine
- •Toxicity with Crystalline Deposits
- •Tamoxifen
- •Canthaxanthine
- •Toxicity Without Fundus Changes
- •Cardiac Glycosides
- •Phosphodiesterase Inhibitors
- •Toxicity with Retinal Edema
- •Methanol
- •Toxicity with Retinal Vascular Changes
- •Talc
- •Oral Contraceptives
- •Interferon
- •Toxicity with Maculopathy
- •Niacin
- •Sympathomimetics
- •Toxicity with Retinal Folds
- •Sulfanilamide-Like Medications
- •Summary
- •Focal Points
- •References
- •Introduction
- •Diabetes
- •Vascular Disease
- •Hypertensive Retinopathy
- •Hypertensive Optic Neuropathy
- •Thrombotic Microangiopathy
- •Dysregulation of the Alternative Complement Pathway with Renal and Ocular Fundus Changes
- •Papillorenal Syndrome
- •Ciliopathies
- •Senior-Loken Syndrome and Related Syndromes with Nephronophthisis
- •Other Rare Metabolic Diseases
- •Congenital Disorders of Glycosylation (CDG)
- •Cystinosis
- •Fabry Disease
- •Peroxisomal Diseases: Refsum Disease
- •Neoplastic Diseases with Kidney and Ocular Involvement
- •von Hippel-Lindau Disease
- •Light Chain Deposition Disease
- •Controversies and Perspectives
- •Focal Points
- •References
- •Index
24 |
J.F. Arévalo et al. |
|
|
Keywords
Ancylostoma caninum • Baylisascaris procyonis • Toxocara canis • Diffuse unilateral subacute neuroretinitis (DUSN)
Introduction
Diffuse unilateral subacute neuroretinitis (DUSN) was described by Gass in 1977 [1], who called it “unilateral wipe-out syndrome.” The term diffuse unilateral subacute neuroretinitis was first used by Gass in 1978 [2]. He described 29 patients seen with consistent features that included insidious, usually severe, loss of peripheral and central vision with associated findings of vitreous inflammation, diffuse and focal epithelial derangement with relative sparing of the macula, narrowing of the retinal vessels, optic atrophy, increased retinal circulation time, and subnormal electroretinographic findings (Fig. 2.1). However, the cause of the inflammation in DUSN was still unknown. In May 1978, Gass et al. reiterated his definition because the progressive unilateral visual loss was believed to be secondary to inflammation of the retina, retinal vessels, retinal pigment epithelium (RPE), and optic nerve head [3]. Later in 1983, Gass and Braunstein observed a nematode in two patients with DUSN [4]. On further searching of the literature, Gass was able to identify previously reported cases of similar nematodes that produced the same clinical picture appearing as early as 1952 [5]. Hence, a syndrome of initially unknown cause that was classified only by clinical description was later found to be related to a nematode in the subretinal space [6]. Although evidence suggests that most patients with DUSN will not develop it in the fellow eye, bilateral cases have been reported; therefore, a more appropriate term for this ocular condition might be diffuse subacute neuroretinitis [7]. Cortez et al. described the clinical features and management in the largest reported series to date of patients with DUSN [8]. The charts of all patients coded as having DUSN in a vitreoretinal clinic in Caracas, Venezuela, between July 1979 and August 2000 were retrospectively reviewed. They identified 82
eyes of 78 patients with DUSN. The mean age at diagnosis was 16.7 years. Thirty-three (42.3%) of the patients were female. The presenting visual acuity was 20/400 or worse in 69 eyes (84.1%). The subretinal nematode was identified in 33 eyes (40.2%), and all nematodes were small, approximately 400 m(mu)m in length [8].
Etiologic Agent
Parasites of different sizes and several species of nematodes have been reported as the etiologic agent of DUSN, including Toxocara canis, Baylisascaris procyonis, and Ancylostoma caninum, and most of these reports do not present conclusive evidence about the specific agent. In the southeastern United States, the Caribbean islands, and South America, the nematode varies in length from approximately 400–700 mm. In the other endemic area, the north Midwestern United States, it measures approximately 1,500–2,000 mm in length [9]. However, Cialdini et al. reported the first South American case of DUSN caused by the larger nematode [10]. In earlier reports, serologic testing was negative in most of the patients with viable intraretinal nematodes, which led Gass and Braunstein to suggest that Toxocara was not the causative nematode in most patients with DUSN [4]. They suggested that the nematode less than 1,000 mm in length was the dog hookworm,
Ancylostoma caninum, and Kazacos et al. suggested that the larger nematode was the raccoon ascarid, Baylisascaris procyonis [11].
Retinal biopsy for DUSN via transcleral approach has been performed by Blumankranz and Culbertson [12]. However, precise identification of the nematode was not made [13]. Gass transclerally extracted one nematode from beneath the retina after killing it with cryotherapy; histologic details were poor, and he was
2 Diffuse Unilateral Subacute Neuroretinitis (DUSN) |
25 |
|
|
Fig. 2.1 (a and b) Patients during early stages usually present mild to moderate vitreitis, mild optic disk edema, and recurrent crops of evanescent, multifocal, gray-white lesions at the level of the outer retina (arrows). These lesions
typically are clustered in only one segment of the fundus. The intraocular worm is seen as a motile, white, often glistening nematode that is gently tapered at both ends and varies in length from 400 to 2,000 mm (inset in b)
unable to identify the nematode [14]. Via transvitreal approach, de Souza et al. recovered the nematode intact and motile [13]. Several parasitologists in São Paulo, Brazil, examined the nematode; the measurement of body size and the morphologic features were more consistent with a third-stage Toxocara larva, but because of poor fixation, definitive identification of the worm was not possible. However, Bowman recently reviewed the pictures of the worm removed by de Souza and concluded that it is most likely Ancylostoma caninum [9]. Because none of the nematodes described from patients with DUSN have been recovered intact, identification must, therefore, be based on a combination of careful measurement of the parasite, serologic testing, and epidemiological studies, all of which have their limitations [15].
infective second-stage larval form of T. canis makes it difficult to be visualize biomicroscopically, (3) the clinical picture is unlike that associated with ocular toxocariasis, and (4) the worldwide prevalence of T. canis is not in keeping with the endemic distribution of DUSN [16]. However, Goldberg et al. reported that low or nondiagnostic serum titers are well described in cases of Toxocara ocular larva migrans and suggested a similarity with the overall reduced sensitivity of serodiagnostic tests for DUSN [15, 17, 18]. Oppenheim et al. reported a case of Toxocara DUSN in which the patient’s positive ELISA titer decreased fourfold over a 2-year period [19]. Therefore, the lack of serologic confirmation of toxocaral infection in some patients may be a reflection of the timing of the serology in relation to the onset of the disease or the immune status of the patient.
Toxocara canis
Gass et al. initially concluded that Toxocara was a cause of DUSN [3] but, however, discarded this possibility based on negative serology in many of the reported patients [4]. In addition, Gass and Olsen later suggested that T. canis was not the cause based on the following: (1) there is a lack of serologic evidence, (2) the small size of the
Ancylostoma caninum
The association of cutaneous larva migrans months, several years, or immediately preceding the onset of DUSN in some patients suggests that
Ancylostoma caninum may be the small nematode that causes the syndrome [9, 16]. A. caninum is a frequent cause of cutaneous larva
